Liposome-paclitaxel and carboplatin combination chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma
CONCLUSIONS: Liposome-paclitaxel and carboplatin concurrent with radiotherapy is a safe and effective modality for locally advanced ESCC. Further clinical investigation are warranted to evaluate the efficacy of this regimen.PMID:33958272 | DOI:10.1016/j.canrad.2021.01.008
Source: Cancer Radiotherapie - Category: Cancer & Oncology Authors: J Zeng X Cui L Cheng Y Chen X Du L Sheng Source Type: research
More News: Academies | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | China Health | Esophagus Cancer | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology